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OBJECTIVES We sought to evaluate the in vivo endothelial function of the radial artery (RA) used as a
coronary graft.
BACKGROUND The RA is becoming a recognized alternative coronary bypass conduit. In vivo endothelial
function is a possible predictor of long-term performance.
METHODS Sixty consecutive patients underwent coronary artery bypass graft surgery (CABG); all
received RA and left internal mammary artery (LIMA) grafts. Three weeks after CABG, 36
patients underwent angiography under basal conditions, during pacing and after intragraft
injection of glyceryl trinitrate (GTN). Angiography was repeated at six months in 20 patients.
RESULTS The estimated mean difference of 66 segments of the radial graft on the first QCA study was
0.170 mm (95% confidence interval [CI] 0.101 to 0.258, p  0.001) between baseline and
pacing, and 0.310 mm (CI 0.225 to 0.401, p  0.001) between baseline and GTN. At six
months, the differences between baseline and pacing and baseline and GTN were 0.112 mm
(CI 0.062 to 0.162, p  0.001) and 0.274 (CI 0.192 to 0.353, p  0.001), respectively. The
difference between baseline values at three weeks and six months was 0.416 mm (CI 0.236 to
0.603, p  0.001). In the LIMA segments, the difference between baseline and pacing and
baseline and GTN were 0.206 mm (CI 0.136 to 0.278, p  0.001) and 0.304 mm (CI 0.213
to 0.396, p 0.001), respectively. At six months, the differences between baseline and pacing
and baseline and GTN were 0.098 mm (CI 0.014 to 0.173, p  0.001) and 0.218 mm (CI
0.130 to 0.298, p  0.001). The difference between baseline values at three weeks and six
months was 0.061 mm (CI 0.064 to 0.176, p  0.05).
CONCLUSIONS In vivo flow-mediated dilation of the RA is comparable to that of pedicled LIMA. The
increased dilation both at baseline and after pacing at six months represents a time-related
improvement in the vasomotor function of the RA, which could have implications for its
performance as a coronary conduit. (J Am Coll Cardiol 2002;39:573–7) © 2002 by the
American College of Cardiology
Superiority of the internal mammary artery (IMA) used as a
bypass graft, compared with the saphenous vein graft
(SVG), is well established. Postoperative follow-up at 15
years showed significantly better survival and freedom from
cardiac events in patients who received one or two IMA
grafts (1). In patients who received a bilateral IMA, there
were decreased risks of death, re-operation and angioplasty,
compared with those who received a single IMA (2,3). In
free IMA grafts, 100% patency at two weeks to six months
was initially reported (4), and a four-year patency rate of
92% was reported by Loop et al. (5). Other arteries—
namely, the right gastroepiploic and the inferior epigastric
arteries—proved disappointing, with an 80% patency rate at
one year (6,7). The inferior epigastric artery was hailed as an
arterial conduit, with characteristics nearly identical to those
of the IMA (8). However, more recently, Perrault et al. (9)
reported their experience with 18 inferior epigastric artery
grafts; a poor 57% patency rate was established before
hospital discharge.
Use of the radial artery (RA) as a free graft is increasing.
The initial work in 1973 yielded encouraging results, with
90% patency at one to 10 months by Carpentier et al. (10).
Despite initial, promising results in subsequent studies,
other investigators found that RA grafts became occluded at
a higher rate than did simultaneously placed IMA and
SVGs (11,12). Fisk et al. (12) advocated that the artery
should not be used, and indeed it was abandoned.
Revival of the RA graft came about when grafts were
shown to be widely patent 15 years after coronary artery
bypass graft surgery (CABG). The philosophy regarding the
role of the RA is changing rapidly, from a graft of last resort
to the graft of second choice after the established left
internal mammary artery (LIMA) pedicled graft. This
increase in the use of the RA graft is occurring despite
limited published data on the in vivo biologic function of
the graft. The capacity of a conduit to dilate in response to
an increased demand could be important in enhancing
patency and performance. The aim of this study was to
characterize the extent of flow-mediated dilation of the RA,
both early and at mid-term.
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METHODS
Patients. Sixty consecutive patients who underwent
CABG between January and July 1998 and received aorto-
coronary RA (five of whom had the RA anastomosed
proximally to a vein graft, creating a Y graft) and pedicled
LIMA grafts were approached. Thirty-six patients (35 men;
mean [SD] age 60  6.5 years) gave written, informed
consent to undergo angiography. All patients were well and
free of angina at the time of the investigation. Patients who
declined to participate had similar characteristics.
Study protocol. All patients received diltiazem orally, 90
mg twice daily, which was discontinued after six months.
Vasoactive medications, including nitrates, beta-blockers,
calcium antagonists and angiotensin-converting enzyme
inhibitors, were discontinued 48 h before angiography. The
femoral artery and vein were percutaneously cannulated. A
6F bipolar pacing lead was positioned in the right atrium,
and the capture threshold and Wenckebach rate were
established. A nonionic contrast medium (Omnipaque) was
used. Two diagnostic pictures of the left coronary artery
and, similarly, two of the right coronary artery were taken.
Two sequences of selective injection into the radial graft
were then done; the first sequence was under the basal
condition and the second was during the last 10 s of 2-min
pacing at a sub-Wenckebach rate. Both sequences were
done at the same settings of the X-ray tube, table and
intensifier, as previously described (13). The second graft
was handled the same way, and the third graft was studied
in three sequences. Two minutes later, these two grafts had
an intragraft injection of 200 g of glyceryl trinitrate
(GTN), and the final sequence of pictures was taken.
Re-cannulation of the RA and the third graft (SVG or right
internal mammary graft) was then done, followed by intra-
graft injection of GTN at 200 g, followed 1 min later by
the final picture sequence. The heart rate and blood pressure
were recorded before and after each contrast injection.
Three RA grafts and two vein grafts were occluded. All
LIMA grafts were patent. Confirmation of occlusion was
made by using two oblique imaging views.
Quantitative coronary angiography (QCA). Quantitative
coronary angiography was done using Medical Imaging
Systems (MEDIS; Nuenen, The Netherlands). A well-
opacified, end-diastolic frame was captured. Each graft was
divided visually into three segments, and an attempt was
made at measuring all segments. When this was impossible,
two segments were measured, at baseline, during pacing and
after nitrate administration, using validated automated
edge-detection algorithms (14). Mean segmental lumen
diameters were obtained. Calibration was done with refer-
ence to the known diameter of the angiographic catheter
2 cm from its tip. Intraobserver and interobserver variabil-
ities were measured and found to be insignificant.
Statistical analysis. The mean differences between baseline
and post-interventions and between baseline values early
and at mid-term are expressed in millimeters, with 95%
confidence intervals (CIs) and p values. Because the values
were not normally distributed, and because some patients
had two segments measured and some had three, depending
on the angiographic suitability for measurement, the Boot-
strap method (15) was used to determine the mean differ-
ence, CI and p value between baseline, pacing and GTN
both at three weeks and six months and between baseline
values at three weeks and six months. Two thousand
bootstrap samples were created to provide an estimate of the
mean difference, to obtain CIs for the mean difference and
to find a p value (for testing whether the mean difference
was zero).
RESULTS
The blood pressure was similar at baseline, during pacing
and after GTN injection. The heart rate was also similar at
baseline and after GTN. In the second QCA study, this
similarity held true, and there was no significant difference
Abbreviations and Acronyms
CABG  coronary artery bypass graft surgery
CI  confidence interval
GTN  glyceryl trinitrate
IMA  internal mammary artery
LAD  left anterior descending coronary artery
LIMA  left internal mammary artery
NO  nitric oxide
QCA  quantitative coronary angiography
RA  radial artery
SVG  saphenous vein graft
Table 1. Mean Heart Rate and Mean Blood Pressure
Conduit
Heart Rate (beats/min) Blood Pressure (mm Hg)
Baseline Pacing GTN Baseline Pacing GTN
RA-1 76  10 138  15 78  10 90  12 88  14 80  16
RA-2 78  12 130  20 80  12 94  13 90  12 89  15
LIMA-1 75  11 138  15 77  12 89  10 92  15 90  14
LIMA-2 80  12 130  20 82  14 92  12 93  13 88  13
Data are presented as the mean value  SD.
GTN  glyceryl trinitrate; LIMA-1  first QCA of the left internal mammary artery at 3 weeks; LIMA-2  second QCA
of the left internal mammary artery at 6 to 8 months; QCA  quantitative coronary angiography; RA-1  first QCA of the
radial artery at 3 weeks after coronary artery bypass graft surgery (CABG); RA-2  second QCA of the radial artery at 6 to 8
months after CABG.
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between the heart rate and blood pressure between the first
and second QCA studies (Table 1).
Angiographic data. Angiography at three weeks after
CABG showed that the baseline diameter of the RA was
smaller than that of the IMA (Tables 2 and 3). Both arterial
grafts became dilated in response to atrial pacing. The
estimated mean differences (mm, with 95% CI and p value)
of 66 segments of the radial graft on the first examination
were 0.170 mm between baseline and pacing (CI 0.101 to
0.258, p  0.001) and 0.310 mm between baseline and
GTN (CI 0.225 to 0.401, p  0.001). At six months, the
mean differences of 60 segments between baseline and
pacing and between baseline and GTN were 0.112 mm (CI
0.062 to 0.162, p  0.001) and 0.274 mm (CI 0.192 to
0.353, p  0.001), respectively. The estimated mean differ-
ence between baseline values at three weeks and six months
was 0.416 mm (CI 0.236 to 0.603, p  0.001). The
estimated mean differences of 69 LIMA segments (at three
weeks) between baseline and pacing and between baseline
and GTN were 0.206 mm (CI 0.136 to 0.278, p  0.001)
and 0.304 mm (CI 0.213 to 0.396, p  0.001), respectively.
At six months, the mean differences of 51 segments between
baseline and pacing and between baseline and GTN were
0.098 mm (CI 0.014 to 0.173, p  0.001) and 0.218 mm
(CI 0.130 to 0298, p  0.001). The estimated mean
difference between baseline values at three weeks and six
months was 0.061 mm (CI 0.064 to 0.176, p  0.05)
(Tables 4 and 5).
Graft patency. Three radial grafts were occluded (92%
patency rate) and two vein grafts were also occluded. All
LIMA grafts were patent.
DISCUSSION
This study has shown that the RA, used as a coronary
bypass conduit, retains the ability to dilate in vivo in
response to an increased heart rate induced by atrial pacing.
This dilation was comparable to that of the pedicled LIMA
and was evident both early (at 3 weeks) and at mid-term (6
to 8 months) after CABG. In addition, we have shown that
the baseline size of the RA increases in the mid-term,
although no such change was observed in the IMA.
Flow-dependent vasodilation. The dilatory response of
the conduit arteries to an augmentation of blood flow
(flow-dependant dilation) was observed over 60 years ago
(16). Atrial pacing increases the myocardial metabolic re-
quirement, causing an increase in coronary blood flow
(17,18). In normal epicardial coronary arteries, this increase
in blood flow is brought about by an increase in blood flow
velocity and by vasodilation (19). Local endothelial-
dependant factors modulate this response, which requires
intact endothelial functional integrity (20); the process is
largely unrelated to innervation (21,22). Our group previ-
ously studied endothelial function in mammary artery grafts
by using substance P and found no significant difference in
the endothelium-dependent and endothelium-independent
vasodilatory responses between free and pedicled mammary
grafts (23). The central role of the endothelium in control-
ling vascular tone has only been appreciated since the
discovery of the potent vasodilators prostacyclin and nitric
oxide (NO) (24,25).
In addition to early postoperative vasospasm, the deter-
minants of vasomotor dysfunction of coronary conduits can
have an impact on the long-term success of the bypass
grafts, as well. The IMAs have been shown to have superior
long-term patency (26). The IMA produces NO, which
induces vasodilation and inhibits platelet adhesion and the
development of atherosclerosis (27). It is postulated that the
greater release of NO by the endothelium in IMA grafts,
compared with SVGs, contributes to the superior results
with this conduit in bypass grafting (28,29).
Endothelial function of the RA versus LIMA. We have
demonstrated that the in vivo function of the endothelium
is comparable between the RA and IMA. It is known that
the RA has a greater degree of contractility, compared with
other conduits, in response to vasopressor agents such
norepinephrine, serotonin, endothelin-1 and angiotensin II
Table 3. Sample Mean Measurement (mm) of Radial Artery at
Baseline, During Pacing and After Glyceryl Trinitrate at Three
Weeks (First QCA) and at Six Months (Second QCA)
Measurement Stage
Sample Mean
Difference 95% CI
QCA at 3 weeks: baseline 2.283 2.035–2.501
QCA at 3 weeks: pacing 2.439 2.202–2.695
QCA at 3 weeks: GTN 2.580 2.319–2.835
QCA at 6 months: baseline 2.682 2.405–2.930
QCA at 6 months: pacing 2.796 2.531–3.024
QCA at 6 months: GTN 2.956 2.700–3.186
CI  confidence interval; other abbreviations as in Table 1.
Table 2. Estimate of Mean Differences (mm) Between Baseline, Pacing and Glyceryl Trinitrate
in the Radial Artery at Three Weeks (First QCA) and at Six Months (Second QCA)
Comparison
Estimate of
Mean Difference 95% CI p Value*
QCA at 3 weeks: baseline vs. pacing 0.170 0.101–0.258  0.001
QCA at 3 weeks: baseline vs. GTN 0.310 0.225–0.401  0.001
QCA at 6 to 8 months: baseline vs. pacing 0.112 0.062–0.162  0.001
QCA at 6 to 8 months: baseline vs. GTN 0.274 0.192–0.353  0.001
QCA baseline at 3 weeks vs. 6 to 8 months 0.416 0.236–0.603  0.001
*For testing whether the mean difference was zero.
CI  confidence interval; other abbreviations as in Table 1.
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(30–32). It appears that the greater propensity of the RA
toward vasospasm is therefore due to the muscular nature of
the media, rather than specific differences in the protection
offered by the endothelium (33,34).
This study demonstrates that the vasomotor tone of the
RA, used as a coronary bypass conduit, is modulated by
changes in blood flow demand caused by an increased heart
rate.
The baseline diameter of the RA at three weeks was
smaller than that of the IMA; this could possibly be due to
differences in the recipient vessels, as the LIMA is grafted to
the left anterior descending coronary artery (LAD), which
carries a greater volume of blood than that in the circumflex
coronary artery. At six months, the baseline size of the RA
increased, whereas the size of the LIMA did not change.
These findings indicate that the thick wall of the RA has no
detrimental effect on the baseline size of the RA, and that
the artery is capable of responding to a long-term persistent
increase in demand by increasing its baseline size. Both
arteries responded to increased blood flow, by significant
vasodilation. This early response to pacing contrasts with
the findings of Gurne et al. (35), who reported no vasodi-
lation in response to atrial pacing in either the mammary or
vein grafts, as well as coronary blood flow that was enhanced
by increased velocity only. Their findings could be partially
explained by the timing of angiography (mean 9 days),
compared with that in our protocol (3 weeks).
Time-related changes in graft size and endothelial func-
tion. Non–endothelial-dependent vasodilation was also
demonstrated, both early and at mid-term. However, in
contrast to the RA, which showed a significant increase in
its mean baseline diameter at six to eight months, repeat
angiography of the LIMA demonstrated a mean diameter
similar to that at baseline. In the LIMA, this may be due to
an early achievement of maximally relaxed vasomotor tone,
which, apparently, took the RA longer to attain. The
response to increased blood flow on the repeat angiogram
was comparable between the RA and LIMA. These changes
differed from the findings of Gurne et al. (36), in their study
of the inferior epigastric artery, where pacing induced
vasodilation late after CABG, but not early postoperatively.
Similar vasomotor changes in the LIMA (pedicled and free)
have been previously reported by Hanet et al. (13), in their
study showing the 6- to 82-month follow-up results after
CABG. The latter study did not include early assessment,
which could have shown a finding similar to ours. The
limitation of the study is the fact that the RA was anasto-
mosed to the circumflex or right coronary artery, and the
LIMA to the LAD. This, too, could have been a factor in
the early occlusions. Two of the RA occlusions were
anastomosed to poor vessels (one was anastomosed to a
vessel with mild stenosis), and these two coronary features
now preclude use of the RA graft. The fact that there were
no further occlusions at six months lends support to the
mechanism of failure of the RA graft as being due to poor
runoff or competitive native flow. A randomized study
comparing the RA and LIMA, both anastomosed to the
LAD, is probably difficult to justify. The long-term patency
will require angiographic analysis similar to that performed
in landmark studies of IMA grafts and SVGs (1,37).
Conclusions and clinical implications. This study has
shown that the in vivo endothelial function of the RA is
retained both early and in the mid-term in a fashion similar
to that of the IMA. In addition, the baseline dimension of
the RA appears to increase with time. These findings
encourage further evaluation and use of the RA graft.
Reprint requests and correspondence: Dr. M. Al-Bustami,
Department of Cardiology, Harefield Hospital, Harefield,
Middlesex, UB9 6JH, United Kingdom. E-mail: mahmud@
doctors.org.uk.
Table 4. Estimate of Mean Difference (mm) Between Baseline, Pacing and Glyceryl Trinitrate
in the Left Internal Mammary Artery at Three Weeks (First QCA) and at Six Months
(Second QCA)
Comparison
Estimate of
Mean Difference 95% CI p Value*
QCA at 3 weeks: baseline vs. pacing 0.206 0.136–0.278  0.001
QCA at 3 weeks: baseline vs. GTN 0.304 0.213–0.396  0.001
QCA at 6 to 8 months: baseline vs. pacing 0.098 0.014–0.173  0.001
QCA at 6 to 8 months: baseline vs. GTN 0.218 0.130–0.298  0.001
QCA baseline at 3 weeks vs. 6 to 8 months 0.061 0.064–0.176 0.309
*For testing whether the mean difference was zero.
CI  confidence interval; other abbreviations as in Table 1.
Table 5. Sample Mean Measurement (mm) of Left Internal
Mammary Artery at Baseline, During Pacing and After Glyceryl
Trinitrate at Three Weeks (First QCA) and at Six Months
(Second QCA)
Measurement Stage
Sample
Mean
Difference 95% CI
QCA at 3 weeks: baseline 2.569 2.394–2.713
QCA at 3 weeks: pacing 2.770 2.590–2.936
QCA at 3 weeks: GTN 2.865 2684–3.035
QCA at 6 months: baseline 2.620 2.421–2.778
QCA at 6 months: pacing 2.711 2.529–2.882
QCA at 6 months: GTN 2.830 2.648–3.015
CI  confidence interval; other abbreviations as in Table 1.
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